Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Cell Biochemistry and Biophysics|December 21, 2018
Recent Advances of Gold Nanoparticles in Biomedical Applications: State of the ArtNegar Sedghi Aminabad, Masoud Farshbaf, Abolfazl Akbarzadeh
Artificial Cells, Nanomedicine, and Biotechnology|April 7, 2016
Magnetic nanoparticles: preparation methods, applications in cancer diagnosis and cancer therapySaeid Shabestari Khiabani, Masoud Farshbaf, Abolfazl Akbarzadeh, et al.
Artificial Cells, Nanomedicine, and Biotechnology|September 22, 2017
Carbon quantum dots: recent progresses on synthesis, surface modification and applicationsMasoud Farshbaf, Soodabeh Davaran, Fariborz Rahimi, et al.
Drug Development and Industrial Pharmacy|November 4, 2017
pH- and thermo-sensitive MTX-loaded magnetic nanocomposites: synthesis, characterization, and in vitro studies on A549 lung cancer cell and MR imagingMasoud Farshbaf, Roya Salehi, Nasim Annabi, et al.
Artificial Cells, Nanomedicine, and Biotechnology|November 7, 2017
Significant role of cationic polymers in drug delivery systemsMasoud Farshbaf, Soodabeh Davaran, Amir Zarebkohan, et al.
International Journal of Pharmaceutics|January 12, 2022
The impact of protein corona on the biological behavior of targeting nanomedicinesMasoud Farshbaf, Hadi Valizadeh, Yunes Panahi, et al.
Artificial Cells, Nanomedicine, and Biotechnology|March 11, 2017
Recent advances on liposomal nanoparticles: synthesis, characterization and biomedical applicationsYunes Panahi, Masoud Farshbaf, Majid Mohammadhosseini, et al.
Expert Opinion on Drug Delivery|June 14, 2022
Transferrin receptor-mediated liposomal drug delivery: recent trends in targeted therapy of cancerSolmaz Mojarad-Jabali, Somayeh Mahdinloo, Masoud Farshbaf, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 1, 2020
Cell surface GRP78: An emerging imaging marker and therapeutic target for cancerMasoud Farshbaf, Ahmad Yari Khosroushahi, Solmaz Mojarad-Jabali, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 18, 2022
Enhanced BBB and BBTB penetration and improved anti-glioma behavior of Bortezomib through dual-targeting nanostructured lipid carriersMasoud Farshbaf, Solmaz Mojarad-Jabali, Salar Hemmati, et al.
Pageof 2